#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16628	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2153	768.2	0	.	n	.	0	A1420G	SNP	1420	1420	A	1687	1687	G	875	G,A	819,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16628	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2153	768.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1717	1717	T	875	T,C	802,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16628	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2153	768.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1451	1451	C	1006	C,G	939,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30780	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3685	833.3	0	.	n	.	0	G1337A	SNP	1337	1337	G	1746	1746	A	1044	A,G	984,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30780	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3685	833.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2380	2380	C	992	C,T	925,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30780	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3685	833.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2454	2454	A	959	A	908	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	30780	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3685	833.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3006	3006	C	940	C	879	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	2176	folP	852	852	99.88	folP.l6.c4.ctg.1	1681	129.2	0	.	p	.	0	P68S	NONSYN	202	204	CCG	669	671	TCG	222;217;222	T;C;G	197;188;198	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	2176	folP	852	852	99.88	folP.l6.c4.ctg.1	1681	129.2	1	SNP	p	R228S	0	.	.	682	684	CGC	1149	1151	CGC	219;221;224	C,A;G;C	210,1;207;212	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5836	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3518	165.2	1	SNP	p	S91F	0	.	.	271	273	TCC	516	518	TCC	188;187;187	T;C;C	176;178;177	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5836	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3518	165.2	1	SNP	p	D95G	0	.	.	283	285	GAC	528	530	GAC	181;180;183	G;A;C	174;170;177	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5836	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3518	165.2	1	SNP	p	D95N	0	.	.	283	285	GAC	528	530	GAC	181;180;183	G;A;C	174;170;177	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1794	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1288	138.3	0	.	p	.	0	A39T	NONSYN	115	117	GCC	406	408	ACC	232;229;229	A;C;C	223;220;223	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1794	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1288	138.3	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	604	606	CAC	234;235;233	C,T;A;C	219,1;217;220	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1794	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1288	138.3	0	.	p	.	0	E117K	NONSYN	349	351	GAA	640	642	AAA	233;230;233	A;A;A	220;217;215	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1794	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1288	138.3	1	SNP	p	G45D	0	.	.	133	135	GGC	424	426	GGC	224;226;228	G;G;C	211;211;212	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	894	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c30.ctg.1	1072	82.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5510	parC	2304	2304	99.7	parC.l6.c4.ctg.1	3118	176.1	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1519	1521	ATC	217;217;218	A;T;C	202;203;203	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5510	parC	2304	2304	99.7	parC.l6.c4.ctg.1	3118	176.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1672	1674	GCA	225;224;224	G;C,G,A;A	209;202,1,1;203	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5510	parC	2304	2304	99.7	parC.l6.c4.ctg.1	3118	176.1	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2155	2157	ATT	264;267;267	A;T;T	242;242;244	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5510	parC	2304	2304	99.7	parC.l6.c4.ctg.1	3118	176.1	1	SNP	p	D86N	0	.	.	256	258	GAC	625	627	GAC	201;200;200	G;A;C	193;191;192	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5510	parC	2304	2304	99.7	parC.l6.c4.ctg.1	3118	176.1	1	SNP	p	S87I	0	.	.	259	261	AGT	628	630	AGT	199;198;200	A;G;T	190;191;191	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5510	parC	2304	2304	99.7	parC.l6.c4.ctg.1	3118	176.1	1	SNP	p	S87R	0	.	.	259	261	AGT	628	630	AGT	199;198;200	A;G;T	190;191;191	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5510	parC	2304	2304	99.7	parC.l6.c4.ctg.1	3118	176.1	1	SNP	p	S87W	0	.	.	259	261	AGT	628	630	AGT	199;198;200	A;G;T	190;191;191	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5510	parC	2304	2304	99.7	parC.l6.c4.ctg.1	3118	176.1	1	SNP	p	S88P	0	.	.	262	264	TCC	631	633	TCC	201;204;206	T;C;C	191;193;196	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4670	parE	1986	1986	99.95	parE.l15.c17.ctg.1	2471	187.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1468	1470	GGC	242;245;245	G;G;C	225;225;226	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2411	193.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1270	1272	GCA	253;254;255	G;C;A,C	224;229;232,1	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2411	193.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1273	1275	ATC	259;258;256	A;T;C,G	236;234;230,1	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2411	193.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1285	1287	GTG	249;246;244	G;T;G	235;230;230	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2411	193.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1285	1287	GTG	249;246;244	G;T;G	235;230;230	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2411	193.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1789	1791	ACC	231;232;233	A;C;CGG,CG	213;219;152,1	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2411	193.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1843	1845	GCG	227;223;220	G;C,G;G	194;175,1;183	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2411	193.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1843	1845	GCG	227;223;220	G;C,G;G	194;175,1;183	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2411	193.8	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1966	1968	GGT	222;222;224	G;G;T,G	210;212;212,1	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2411	193.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1975	1977	GGC	225;221;221	G;G;C	214;204;209	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4694	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2411	193.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1993	1995	CCG	203;203;203	C;C;G	143;181;161	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6452	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3139	204.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2390	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1820	130.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	493	493	C	156	C	143	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3378	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1445	231.6	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	680	682	CAA	263;262;257	C,A;A;A	239,1;242;236	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3378	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1445	231.6	0	.	p	.	0	E212S	NONSYN	634	636	GAA	887	889	AGT	260;257;255	A;G;T	250;250;242	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3378	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1445	231.6	0	.	p	.	0	H213D	NONSYN	637	639	CAT	890	892	GAT	254;258;254	G;A;T	242;247;245	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3378	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1445	231.6	0	.	p	.	0	V215A	NONSYN	643	645	GTT	896	898	GCT	260;260;257	G;C;T,A	251;252;248,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3378	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1445	231.6	0	.	p	.	0	I218M	NONSYN	652	654	ATC	905	907	ATG	270;270;273	A;T;G,C	263;261;259,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3378	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1445	231.6	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1022	1024	AAG	276;276;275	A;A;G	261;261;261	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3378	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1445	231.6	1	SNP	p	G120K	0	.	.	358	360	GGC	611	613	GGC	264;253;252	G;G;C	251;241;240	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	12482	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4851	256.5	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1973	1975	CAT	266;266;264	C;A;T	250;252;250	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1386	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1122	122.9	1	SNP	p	V57M	0	.	.	169	171	GTG	622	624	GTG	276;279;276	G,A;T;G	259,1;262;258	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
